Concepedia

Ruby Mehta

RM

Statistics

Publications

3

Citations

89

H-Index

3

Active since

2020

Affiliations

United States Food and Drug Administration(Current)

Indiana University School of Medicine

Center for Drug Evaluation and Research

Virginia Commonwealth University

University of California, Berkeley

Ruby Mehta is an author at United States Food and Drug Administration specializing in medicine, hepatology, and liver disease.

Publications per year

2020–2023

3

Publications

3

Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug Administration

Frank A. Anania, Lara Dimick‐Santos, Ruby Mehta et al. · Hepatology · 2020 · 51 citations

Medicine, Internal Medicine, Nutrition +16

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

Mazen Noureddin, Jean L. Chan, Katherine Barradas et al. · Gastroenterology · 2020 · 25 citations · Full text

Medicine, Internal Medicine, Clinical Trial Regulation +10

Liver biopsy for assessment of suspected drug‐induced liver injury in metabolic dysfunction‐associated steatohepatitis clinical trials: Expert consensus from the Liver Forum

Melissa Palmer, David E. Kleiner, Zachary Goodman et al. · Alimentary Pharmacology & Therapeutics · 2023 · 13 citations · Full text

Medicine, Pathology, Pharmacology +16

1–3 of 3